Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report
Background: Hepatitis B virus infection is the most common cause of chronic hepatitis. Vertical transmission is the main transmission route of this virus. Current prevention involves giving newborns immune prophylaxis within 12 hours of birth. However, there is still a failure of immunoprophylaxis,...
Saved in:
Main Authors: | Ris Raihan Felim, Irsan Hasan, Erni Juwita Nelwan |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2024-10-01
|
Series: | Acta Medica Indonesiana |
Subjects: | |
Online Access: | http://www.actamedindones.org/index.php/ijim/article/view/2585 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors predicting renal impairment associated with Tenofovir Disoproxil fumarate: Focus on patients with HIV and pre-existing metabolic abnormalities under the Thai National Health Security Scheme
by: Duangjai Duangrithi, et al.
Published: (2025-08-01) -
Rapid suppression of HBV replication before related liver transplantation in a patient with HDV superinfection. Clinical case report
by: U. R. Salimov, et al.
Published: (2024-09-01) -
Monitoring the Effects of Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Switch for Tubulotoxicity in Highly Treatment-Experienced or in Very Sick Individuals Infected with HIV
by: Nicole Marie Lioufas, et al.
Published: (2018-06-01) -
Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial
by: Hyung Joon Yim, et al.
Published: (2025-07-01) -
Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy.
by: Yi Lin, et al.
Published: (2025-01-01)